Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combined analysis of three Lynch syndrome cohorts confirms the modifying effects of 8q23.3 and 11q23.1 in MLH1 mutation carriers.
Talseth-Palmer BA, Wijnen JT, Brenne IS, Jagmohan-Changur S, Barker D, Ashton KA, Tops CM, Evans TJ, McPhillips M, Groombridge C, Suchy J, Kurzawski G; Dutch Cancer Genetics Group; Spigelman A, Møller P, Morreau HM, Van Wezel T, Lubinski J, Vasen HF, Scott RJ. Talseth-Palmer BA, et al. Among authors: wijnen jt. Int J Cancer. 2013 Apr 1;132(7):1556-64. doi: 10.1002/ijc.27843. Epub 2012 Oct 11. Int J Cancer. 2013. PMID: 22987364 Free article.
Genetic modifiers of cancer risk in Lynch syndrome: a review.
Talseth-Palmer BA, Wijnen JT, Grice DM, Scott RJ. Talseth-Palmer BA, et al. Among authors: wijnen jt. Fam Cancer. 2013 Jun;12(2):207-16. doi: 10.1007/s10689-013-9614-2. Fam Cancer. 2013. PMID: 23471748 Free PMC article. Review.
Reply to Win and Jenkins.
Talseth-Palmer BA, Wijnen JT, Barker D, Vasen HF, Scott RJ. Talseth-Palmer BA, et al. Among authors: wijnen jt. Int J Cancer. 2013 Oct 1;133(7):1764. doi: 10.1002/ijc.28178. Epub 2013 Apr 18. Int J Cancer. 2013. PMID: 23536415 Free article. No abstract available.
The importance of a large sample cohort for studies on modifier genes influencing disease severity in FAP patients.
Talseth-Palmer BA, Wijnen JT, Andreassen EK, Barker D, Jagmohan-Changur S, Tops CM, Meldrum C; Dutch Cancer Genetics Group; Spigelman A, Hes FJ, Van Wezel T, Vasen HF, Scott RJ. Talseth-Palmer BA, et al. Among authors: wijnen jt. Hered Cancer Clin Pract. 2013 Dec 29;11(1):20. doi: 10.1186/1897-4287-11-20. Hered Cancer Clin Pract. 2013. PMID: 24373140 Free PMC article.
A genetic variant in telomerase reverse transcriptase (TERT) modifies cancer risk in Lynch syndrome patients harbouring pathogenic MSH2 variants.
Wiik MU, Evans TJ, Belhadj S, Bolton KA, Dymerska D, Jagmohan-Changur S, Capellá G, Kurzawski G, Wijnen JT, Valle L, Vasen HFA, Lubinski J, Scott RJ, Talseth-Palmer BA. Wiik MU, et al. Among authors: wijnen jt. Sci Rep. 2021 May 31;11(1):11401. doi: 10.1038/s41598-021-90501-2. Sci Rep. 2021. PMID: 34059744 Free PMC article.
159 results